Blastocyst Culture Using Time-lapse in Good Prognosis IVF Patients and Elective Single Embryo Transfer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

64 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-12-31

Study Completion Date

2012-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Choosing the best embryo for transfer has become the major challenge in in vitro fertilization (IVF). Morphology alone is obviously not enough and time-lapse incubation has added embryo development kinetics as another selection criterion.

This study was designed to select for the top blastocyst to be replaced, while increasing the pregnancy chance, with the local legislation regulating the number of embryos to be transferred and to establish a morphokinetic standard to be used in our clinical setting.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Idealizing Pregnancy Outcome With Single Blastocyst Transfer in a FET Cycle

NCT01987856

Pregnancy

WITHDRAWN NA

Comparing Pregnancy Outcomes in Good Prognosis Patients Between Fresh and 'Freeze-All' Single Blastocyst Transfers

NCT02712840

Infertility

TERMINATED NA

Evaluation of Blastocyst Morphology and Quality in Patients With Embryo Transfer at the Blastocyst Stage

NCT05510557

Infertility

UNKNOWN

Blastocyst Culture in a Time-lapse Incubator

NCT02778217

Sub-optimal Culture Conditions

UNKNOWN NA

Direct Thawing of Vitrified Human Blastocyst

NCT06322823

IVF

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infertility

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Conventional incubation

Five-day embryo culture in conventional incubators

Group Type NO_INTERVENTION

No interventions assigned to this group

Embryoscope

Five-day embryo culture in embryoscope which is an incubator with a built-in camera

Group Type ACTIVE_COMPARATOR

Embryoscope

Intervention Type DEVICE

Five-day embryo culture in embryoscope which is an incubator with a built-in camera

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Embryoscope

Five-day embryo culture in embryoscope which is an incubator with a built-in camera

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Time-lapse monitoring of human embryos in Embryoscope

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients in their first or second ART treatment cycle
* no recurrent spontaneous abortions
* age\<35 years
* BMI\<28 kg/m2
* ≥8 oocytes retrieved

Exclusion Criteria

* severe endometriosis
* polycystic ovary syndrome
* hydrosalpynx
* uterine pathology
* severe male factor (presenting less than 5 million motile sperm cells in total in the ejaculate)
* very severe morphological sperm defects (mainly globozoospermic or macrocephalic samples)

Minimum Eligible Age

20 Years

Maximum Eligible Age

35 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No